Methods of treating cancer by targeting tumor-associated macrophages
US-2024415921-A1 · Dec 19, 2024 · US
US9345741B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9345741-B2 |
| Application number | US-201313833039-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2013 |
| Priority date | Mar 15, 2013 |
| Publication date | May 24, 2016 |
| Grant date | May 24, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to nutritional compositions including a protein equivalent source that includes a peptide component comprising selected peptides. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of promoting healthy body weight in a target subject by stimulating adiponectin levels by providing the nutritional compositions disclosed herein to a target subject, which includes a pediatric subject.
Opening claim text (preview).
What is claimed is: 1. A nutritional composition comprising: (i) a carbohydrate; (ii) a fat; and (iii) a protein equivalent, wherein (a) at least 20% of the protein equivalent includes a casein hydrolysate having a molar mass distribution of greater than 500 Daltons, and (b) at least 20% to 80% of the protein equivalent comprises a peptide component, wherein the peptide component consists of the following individual peptides: SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, and SEQ ID NO 63; further wherein the peptide component is present in amount of from about 0.2 g/100 kcals to about 5.6 g/100 kcals of the nutritional composition. 2. The nutritional composition of claim 1 , wherein the peptide component further comprises at least 10 individual peptides selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11, SEQ ID NO 12, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 33, SEQ ID NO 34, SEQ ID NO 35, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38, SEQ ID NO 39, SEQ ID NO 40, SEQ ID NO 41, SEQ ID NO 42, SEQ ID NO 43, SEQ ID NO 44, SEQ ID NO 45, SEQ ID NO 46, SEQ ID NO 47, SEQ ID NO 48, SEQ ID NO 49, SEQ ID NO 50, SEQ ID NO 52, SEQ ID NO 53, SEQ ID NO 54, SEQ ID NO 55, SEQ ID NO 56, SEQ ID NO 58, SEQ ID NO 59, SEQ ID NO 61, SEQ ID NO 62, and SEQ ID NO 64. 3. The nutritional composition of claim 1 , wherein the protein equivalent comprises partially hydrolyzed protein having a degree of hydrolysis of less than 40%. 4. The nutritional composition of claim 1 , further comprising at least one long-chain polyunsaturated fatty acid. 5. The nutritional composition of claim 4 , wherein the at least one long-chain polyunsaturated fatty acid is selected from the group consisting of docosahexaenoic acid and arachidonic acid. 6. The nutritional composition of claim 1 , further comprising a culture supernatant from a late-exponential growth phase of a probiotic batch-cultivation process. 7. The nutritional composition of claim 1 , further comprising a probiotic. 8. The nutritional composition of claim 1 , further comprising a prebiotic. 9. A nutritional composition, comprising: (i) a carbohydrate; (ii) a fat; and (iii) a protein equivalent; wherein (a) at least 20% of the protein equivalent comprises a casein hydrolysate having a molar mass distribution of greater than 500 Daltons, and (b) at least 20% of the protein equivalent comprises a peptide component, wherein the peptide component consists of at least 5 individual peptides selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11, SEQ ID NO 12, SEQ ID NO 14, SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 33, SEQ ID NO 34, SEQ ID NO 35, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38, SEQ ID NO 39, SEQ ID NO 40, SEQ ID NO 41, SEQ ID NO 42, SEQ ID NO 43, SEQ ID NO 44, SEQ ID NO 45, SEQ ID NO 46, SEQ ID NO 47, SEQ ID NO 48, SEQ ID NO 49, SEQ ID NO 50, SEQ ID NO 52, SEQ ID NO 53, SEQ ID NO 54, SEQ ID NO 55, SEQ ID NO 56, SEQ ID NO 58, SEQ ID NO 59, SEQ ID NO 61, SEQ ID NO 62, SEQ ID NO 64; and at least 3 individual peptides selected from SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, SEQ ID NO 63, wherein the peptide component is present in the nutritional composition in an amount of from about 0.2 g/100 kcals to about 5.6 g/100 kcals. 10. The nutritional composition of claim 9 , wherein the protein equivalent comprises partially hydrolyzed protein having a degree of hydrolysis of less than 40%. 11. The nutritional composition of claim 9 , further comprising a prebiotic. 12. The nutritional composition of claim 9 , further comprising a culture supernatant from a late-exponential growth phase of a probiotic batch-cultivation process. 13. The nutritional composition of claim 1 , wherein the nutritional composition further comprises intact protein. 14. The nutritional composition of claim 9 , wherein the nutritional composition further comprises intact protein. 15. The nutritional composition of claim 1 , comprising from about 1 g to about 7 g of protein equivalent per 100 kcal of nutritional composition. 16. The nutritional composition of claim 9 , comprising from about 1 g to about 7 g of protein equivalent per 100 kcal of nutritional composition. 17. The nutritional composition of claim 1 , comprising from about 5 g/100 kcal to about 25 g/100 kcal of a carbohydrate. 18. The nutritional composition of claim 9 , comprising from about 5 g/100 kcal to about 25 g/100 kcal of a carbohydrate.
Bacteria or derivatives thereof, e.g. probiotics · CPC title
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Fatty acids or derivatives thereof · CPC title
Peptides; Protein hydrolysates · CPC title
Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.